区分用于ICH M7下应用的专家系统和统计系统。 - Suppr

Suppr

超能文献

Distinguishing between expert and statistical systems for application under ICH M7.

作者信息

Barber Chris, Hanser Thierry, Judson Philip, Williams Richard

机构信息

Lhasa Limited, Granary Wharf House, 2 Canal Wharf, Leeds LS11 5PY, UK.

Heather Lea Cottage, Bland Hill, Norwood, Harrogate HG3 1TE, UK.

出版信息

Regul Toxicol Pharmacol. 2017 Mar;84:124-130. doi: 10.1016/j.yrtph.2016.12.012. Epub 2017 Jan 3.

DOI:10.1016/j.yrtph.2016.12.012

PMID:28057482

Abstract

摘要

相似文献

Distinguishing between expert and statistical systems for application under ICH M7.区分用于ICH M7下应用的专家系统和统计系统。

Regul Toxicol Pharmacol. 2017 Mar;84:124-130. doi: 10.1016/j.yrtph.2016.12.012. Epub 2017 Jan 3.

Carbamates and ICH M7 classification: Making use of expert knowledge.氨基甲酸酯类与ICH M7分类：利用专家知识

Regul Toxicol Pharmacol. 2017 Jun;86:392-401. doi: 10.1016/j.yrtph.2017.03.025. Epub 2017 Apr 4.

Establishing best practise in the application of expert review of mutagenicity under ICH M7.在国际人用药品注册技术协调会（ICH）M7指导原则下建立致突变性专家评审应用的最佳实践。

Regul Toxicol Pharmacol. 2015 Oct;73(1):367-77. doi: 10.1016/j.yrtph.2015.07.018. Epub 2015 Aug 4.

Principles and procedures for implementation of ICH M7 recommended (Q)SAR analyses.国际人用药品注册技术协调会M7指导原则中推荐的（定量）构效关系分析的实施原则与程序

Regul Toxicol Pharmacol. 2016 Jun;77:13-24. doi: 10.1016/j.yrtph.2016.02.004. Epub 2016 Feb 11.

(Q)SAR assessments of potentially mutagenic impurities: a regulatory perspective on the utility of expert knowledge and data submission.潜在诱变杂质的（定量）构效关系评估：关于专家知识和数据提交效用的监管视角

Regul Toxicol Pharmacol. 2015 Mar;71(2):295-300. doi: 10.1016/j.yrtph.2014.12.012. Epub 2014 Dec 26.

Transitioning to composite bacterial mutagenicity models in ICH M7 (Q)SAR analyses.向 ICH M7（Q）SAR 分析中的组合细菌致突变性模型过渡。

Regul Toxicol Pharmacol. 2019 Dec;109:104488. doi: 10.1016/j.yrtph.2019.104488. Epub 2019 Oct 3.

A consortium-driven framework to guide the implementation of ICH M7 Option 4 control strategies.一个由联盟驱动的框架，用于指导 ICH M7 选项 4 控制策略的实施。

Regul Toxicol Pharmacol. 2017 Nov;90:22-28. doi: 10.1016/j.yrtph.2017.08.008. Epub 2017 Aug 16.

Use of in silico systems and expert knowledge for structure-based assessment of potentially mutagenic impurities.基于计算机系统和专家知识的潜在致突变杂质的结构评估。

Regul Toxicol Pharmacol. 2013 Oct;67(1):39-52. doi: 10.1016/j.yrtph.2013.05.001. Epub 2013 May 10.

Extending (Q)SARs to incorporate proprietary knowledge for regulatory purposes: A case study using aromatic amine mutagenicity.扩展定量构效关系以纳入用于监管目的的专有知识：以芳香胺致突变性为例的案例研究

Regul Toxicol Pharmacol. 2016 Jun;77:1-12. doi: 10.1016/j.yrtph.2016.02.003. Epub 2016 Feb 13.

Assessing the impact of expert knowledge on ICH M7 (Q)SAR predictions. Is expert review still needed?评估专家知识对ICH M7（Q）SAR 预测的影响。专家评审是否仍然必要？

Regul Toxicol Pharmacol. 2021 Oct;125:105006. doi: 10.1016/j.yrtph.2021.105006. Epub 2021 Jul 14.

引用本文的文献

Matrine and Oxymatrine: evaluating the gene mutation potential using in silico tools and the bacterial reverse mutation assay (Ames test).苦参碱和氧化苦参碱：利用计算机工具和细菌回复突变试验（Ames 试验）评估基因突变潜力。

Mutagenesis. 2024 Feb 8;39(1):32-42. doi: 10.1093/mutage/gead032.

In silico toxicology: From structure-activity relationships towards deep learning and adverse outcome pathways.计算机毒理学：从构效关系到深度学习及不良结局途径。

Wiley Interdiscip Rev Comput Mol Sci. 2020 Jul-Aug;10(4):e1475. doi: 10.1002/wcms.1475. Epub 2020 Mar 31.

Quantitative Determination of Four Potential Genotoxic Impurities in the Active Pharmaceutical Ingredients in TSD-1 Using UPLC-MS/MS.采用 UPLC-MS/MS 定量测定 TSD-1 中活性药物成分中的四种潜在遗传毒性杂质。

Molecules. 2022 Jun 27;27(13):4129. doi: 10.3390/molecules27134129.

Use of transcriptomics in hazard identification and next generation risk assessment: A case study with clothianidin.使用转录组学进行危害识别和下一代风险评估：以噻虫嗪为例。

Food Chem Toxicol. 2022 Aug;166:113212. doi: 10.1016/j.fct.2022.113212. Epub 2022 Jun 8.

Use of Lhasa Limited Products for the In Silico Prediction of Drug Toxicity.利用拉萨有限产品进行药物毒性的计算机预测。

Methods Mol Biol. 2022;2425:435-478. doi: 10.1007/978-1-0716-1960-5_17.

Discovery of new acetylcholinesterase inhibitors for Alzheimer's disease: virtual screening and characterisation.用于治疗阿尔茨海默病的新型乙酰胆碱酯酶抑制剂的发现：虚拟筛选和特性研究。

J Enzyme Inhib Med Chem. 2021 Dec;36(1):491-496. doi: 10.1080/14756366.2021.1876685.

Management of pharmaceutical ICH M7 (Q)SAR predictions - The impact of model updates.药品人用药品注册技术协调会国际协调会议（ICH）M7定量构效关系（QSAR）预测的管理——模型更新的影响

Regul Toxicol Pharmacol. 2020 Dec;118:104807. doi: 10.1016/j.yrtph.2020.104807. Epub 2020 Oct 13.

The importance of expert review to clarify ambiguous situations for (Q)SAR predictions under ICH M7.专家评审对于根据国际人用药品注册技术协调会M7指导原则澄清(Q)SAR预测中模糊情况的重要性。

Genes Environ. 2020 Sep 22;42:27. doi: 10.1186/s41021-020-00166-y. eCollection 2020.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验